Mylan, Pfizer Receive EC Approval For Proposed Combination Of Mylan And Upjohn

(RTTNews) - Mylan (MYL) and Pfizer Inc. (PFE) announced that the companies have received final approval from the European Commission or EC for the proposed combination of Mylan and Pfizer Inc.'s Upjohn business.

As previously disclosed, in April 2020, the EC issued a conditional approval that was subject to the divestiture of certain of Mylan's products in Europe. The EC has approved the proposed divestiture buyers and Mylan has entered into agreements with those buyers on terms that the EC has accepted, which are substantially in line with Mylan's previously stated expectations.

Additionally, the companies received approval from the Australian Competition and Consumer Commission and the New Zealand Commerce Commission related to the combination of Mylan and Pfizer's Upjohn business.